Article
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease
3 Nov 2016
Abstract excerpt
BACKGROUND: Synuclein gamma (SNCG) expression is associated with advanced disease and chemoresistance in multiple solid tumors. Our goal was to determine if SNCG protein expression in ovarian cancer was correlated with clinicopathologic variables and patient outcomes. METHODS: Tissue microarrays from primary tumors of 357 ovarian, fallopian tube, and primary peritoneal cancer patients, who underwent primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
